Nature Communications · 2024 · 41 citations · 52 references
Life SciencesImmunologyMolecular BiologyImmunotherapyMass Spectrometric AnalysisProteomicsHuman Leukocyte Antigen SystemMass SpectrometryMass Spectrometry Data AnalysisMass Spectrometry-based ProteomicsPeptide AnalysisPeptide IdentificationIon Mobility SpectrometryLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisMass Spectrometry ImmunopeptidomicsPeptide Fragmentation PredictionPeptide Identification ScoringPeptide Mass SpectrometryTandem Mass Spectrometry
Abstract Human leukocyte antigen (HLA) class I peptide ligands (HLAIps) are key targets for developing vaccines and immunotherapies against infectious pathogens or cancer cells. Identifying HLAIps is challenging due to their high diversity, low abundance, and patient individuality. Here, we develop a highly sensitive method for identifying HLAIps using liquid chromatography-ion mobility-tandem mass spectrometry (LC-IMS-MS/MS). In addition, we train a timsTOF-specific peak intensity MS 2 PIP model for tryptic and non-tryptic peptides and implement it in MS 2 Rescore (v3) together with the CCS predictor from ionmob. The optimized method, Thunder-DDA-PASEF, semi-selectively fragments singly and multiply charged HLAIps based on their IMS and m/z. Moreover, the method employs the high sensitivity mode and extended IMS resolution with fewer MS/MS frames (300 ms TIMS ramp, 3 MS/MS frames), doubling the coverage of immunopeptidomics analyses, compared to the proteomics-tailored DDA-PASEF (100 ms TIMS ramp, 10 MS/MS frames). Additionally, rescoring boosts the HLAIps identification by 41.7% to 33%, resulting in 5738 HLAIps from as little as one million JY cell equivalents, and 14,516 HLAIps from 20 million. This enables in-depth profiling of HLAIps from diverse human cell lines and human plasma. Finally, profiling JY and Raji cells transfected to express the SARS-CoV-2 spike protein results in 16 spike HLAIps, thirteen of which have been reported to elicit immune responses in human patients.
52
Universal sample preparation method for proteome analysis
Jacek R. Wiśniewski, Alexandre Zougman, Nagarjuna Nagaraj et al. · Nature Methods · 2009 · 8.7K citations
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon, Gwendolyn Μ. Jang, Mehdi Bouhaddou et al. · Nature · 2020 · 4.9K citations · Full text
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang, Gang Ye, Ke Shi et al. · Nature · 2020 · 4.1K citations · Full text
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eran Eden, Roy Navon, Israel Steinfeld et al. · BMC Bioinformatics · 2009 · 3.7K citations · Full text